recombinant hepatitis B protein (Xiamen Innovax Biotech/Xiamen University)

N/A

Report date: 2025/03/20 09:12:13

Base Information

Drug Namerecombinant hepatitis B protein (Xiamen Innovax Biotech/Xiamen University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen Innovax Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Innovax Biotech Co LtdXiamen University
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A